Dermisonics Financial Statements From 2010 to 2025
Dermisonics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Dermisonics' valuation are provided below:Dermisonics does not presently have any fundamental signals for analysis.
Check out the analysis of Dermisonics Correlation against competitors. For more detail on how to invest in Dermisonics Stock please use our How to Invest in Dermisonics guide.
Check Dermisonics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dermisonics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Dermisonics financial statements analysis is a perfect complement when working with Dermisonics Valuation or Volatility modules.
Dermisonics | Build AI portfolio with Dermisonics Stock |
Dermisonics Company Shares Outstanding Analysis
Dermisonics' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Dermisonics Shares Outstanding | 63.91 M |
Most of Dermisonics' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dermisonics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Dermisonics has 63.91 M of shares currently outstending. This is 64.6% lower than that of the Healthcare sector and 63.47% lower than that of the Medical Devices industry. The shares outstanding for all United States stocks is 88.82% higher than that of the company.
Dermisonics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Dermisonics's current stock value. Our valuation model uses many indicators to compare Dermisonics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Dermisonics competition to find correlations between indicators driving Dermisonics's intrinsic value. More Info.Dermisonics is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Dermisonics' earnings, one of the primary drivers of an investment's value.About Dermisonics Financial Statements
Investors use fundamental indicators, such as Dermisonics' revenue or net income, to determine how well the company is positioned to perform in the future. Although Dermisonics' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Dermisonics, Inc. manufactures ultrasonic transdermal drug-delivery technologies and equipment. Dermisonics, Inc. was founded in 2000 and is based in Irvine, California. Dermisonics is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out the analysis of Dermisonics Correlation against competitors. For more detail on how to invest in Dermisonics Stock please use our How to Invest in Dermisonics guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Medical Devices space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dermisonics. If investors know Dermisonics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dermisonics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Dermisonics is measured differently than its book value, which is the value of Dermisonics that is recorded on the company's balance sheet. Investors also form their own opinion of Dermisonics' value that differs from its market value or its book value, called intrinsic value, which is Dermisonics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dermisonics' market value can be influenced by many factors that don't directly affect Dermisonics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dermisonics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dermisonics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dermisonics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.